IP Verse

Merz Pharmaceuticals vs. Viatris Sante - UPC_CFI_697/2025

The case UPC_CFI_697/2025 was filed by the plaintiff Merz Pharmaceuticals against the defendant Viatris Sante on 31 Jul, 2025.

Case Timeline

31 Jul, 2025
Case Filed
01 Oct, 2025
Reply Filed
01 Oct, 2025
Written Procedure
01 Oct, 2025
Oral Procedure
Today Nov 1, 2025
Decision

Case Details

    Case Number:

    UPC_CFI_697/2025

    Patent Number:

    EP2377536

    Filing Date:

    31 Jul, 2025

    Proceeding Type:

    Provisionalmeasures

    Case Phase:

    Written Phase

    Plaintiffs:

    • Merz Pharmaceuticals
    • Merz Pharma France
    • Merz Therapeutics

    Plaintiff Representative:

    • Laëtitia BÉNARD

    Defendants:

    • Viatris Sante

    Defendant Representative:

    • Marc Lauzeral

    Judges:

    • Camille Lignieres
    • Carine Gillet
    • Rainer Friedrich
    • Samuel Granata

    Court Division:

    First Instance, Local Division - Paris

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Oct 10, 2025Action.Communication
Oct 9, 2025Receipt
Oct 9, 2025Proof Of Payment
Oct 9, 2025Other Document
Oct 9, 2025Fee
Oct 9, 2025Cover Sheet
Oct 9, 2025Application
Oct 7, 2025Order
Oct 7, 2025Action.Issueorder
Oct 6, 2025Action.Communication
Oct 5, 2025Receipt
Oct 5, 2025Cover Sheet
Oct 5, 2025Application
Oct 2, 2025Receipt
Oct 2, 2025Order
Oct 2, 2025Cover Sheet
Oct 2, 2025Application
Oct 2, 2025Action.Issueorder
Oct 1, 2025Statement Of Reply
Oct 1, 2025Receipt
Oct 1, 2025Exhibit
Oct 1, 2025Cover Sheet
Oct 1, 2025Application
Sep 26, 2025Action.Communication
Sep 25, 2025Receipt
Sep 25, 2025Other Document
Sep 25, 2025Exhibit
Sep 25, 2025Cover Sheet
Sep 25, 2025Action.Communication
Sep 24, 2025Order
Sep 24, 2025Action.Issueorder
Sep 18, 2025Request V.Def Pdf A Signed
Sep 18, 2025Receipt
Sep 18, 2025Pc154 Iqvia Agreement Gb
Sep 18, 2025Pc149 Iqvia Data Unredacted Version Gb
Sep 17, 2025Receipt
Sep 17, 2025Procedural Order
Sep 17, 2025Outcome Of The Order
Sep 17, 2025Headnote And Keywords
Sep 16, 2025Request For Procedural Order
Sep 16, 2025Receipt
Sep 16, 2025Objection
Sep 15, 2025Pj087 Regulation N 469 Gb
Sep 15, 2025Pj086 Court Of Appeal 10X Genomics Harvard V Nanostring Upc Coa 3352023 Gb
Sep 15, 2025Pj085 Dmf Nl Court Of The Hague 1Ere Instance Nl
Sep 15, 2025Pj084 Dmf Be Cour Dappel De Bruxelles Appel Nl
Sep 15, 2025Pj083 Fingolimod De Olg Dusseldorf Appel De
Sep 15, 2025Pj082 Phosphodiesterase Nl Appeal Court Of The Hague Appel Nl
Sep 15, 2025Pj081 Dmf De Olg Dusseldorf Appel De
Sep 15, 2025Pj080 Munich Local Division 21 May Upccfi432023 De
Sep 15, 2025Pj079 Ca Paris 9 July N2407962 Fr
Sep 15, 2025Pj078 Case Law Of The Boards Of Appeal Id108 Gb
Sep 15, 2025Pj077 Bonnes Pratiques De Distribution Ansm Bulletin Officiel N20149Bis Fr
Sep 15, 2025Pj076 Upc Court Of Appeal 25 September Upccoa1822024 Gb
Sep 15, 2025Pj075 Guidelines For Examination In The European Patent Office Gvii4Gb
Sep 15, 2025Pj074 Decision De La Chambre De Recours De Loeb DU 4 October T 111003 Gb
Sep 15, 2025Pj073 Epo Boa 10 July Eisai V Stada Lenvatinib T 193423 Gb
Sep 15, 2025Pj072 Hamburg Local Division 3 June Upccfi1512024 Gb
Sep 15, 2025Pj071 Dusseldorf Local Division 30 April Upccfi4632023 Gb
Sep 15, 2025Pj070 Dusseldorf Local Division 9 April Upccfi4522023 De
Sep 15, 2025Pj069 Dusseldorf Local Division VALEO V Magna Upc Cfi 3682024 Gb
Sep 15, 2025Pj068 Court Of Appeal Biolitec V Light Guide Optics Sia Lightguide 24 February Upccoa5402024 Gb
Sep 15, 2025Pj067 Ld Munich 15 November Upc Cfi 152023 Gb
Sep 15, 2025Pj065 Cjeu 28 July Synthon C Mertz Memantine C19509 Gb
Sep 15, 2025Pj064 Cjeu 28 July Generics Uk C Synaptech Galantamine C42709 Gb
Sep 15, 2025Pj063 Cass Com 10 February N1320150 Fr
Sep 15, 2025Pj062 Directive 200448CE Gb
Sep 15, 2025Pj061 Neurim Mylan High Court Of Justice 3 June Ewhc 1362 Gb
Sep 15, 2025Pj060 Decision De La Chambre De Recours De Loeb 13 September T023916 Gb
Sep 15, 2025Pj059 Decision De La Chambre De Recours De Loeb 4 October T250612 Gb
Sep 15, 2025Pj058 Tj Paris Refere 17 June Rg 2153849 Cabazitaxel Sanofi C Ever Pharma Fr
Sep 15, 2025Pj057 Tj Paris 12 May Rg 2153136 Cabazitaxel Sanofi C Teva Fr
Sep 15, 2025Pj056 Santen C 673 18 Gb
Sep 15, 2025Pj055 Tgi Paris 22 September 1407707 Fr
Sep 15, 2025Pj054 Cour Dappel De Paris 14 February 1991 Newtec International C Sfeima Pibd N504 Iiii432 Fr
Sep 15, 2025Pj053 Cour De Cassation 20 November Pourvoi N 1118440 Fr
Sep 15, 2025Pj052 Tgi Paris 6 June Rg N1606916 Fr
Sep 15, 2025Pj051 Tgi Rennes 2 September Rg N9803029 Fr
Sep 15, 2025Pj050 Decision De La Chambre De Recours 3306 De Loeb 30 May T 16596 Fr
Sep 15, 2025Pj049 Decision De La Chambre De Recours 3502 De Loeb 29 October T 33515 Fr
Sep 15, 2025Pj048 Decision De La Chambre De Recours De Loeb 10 November 1988 T038187 Gb
Sep 15, 2025Pj047 Tj Paris 22 June Rg N2002792 Fr
Sep 15, 2025Pj046 Decision De La Chambre De Recours De Loeb 20 September T197909 Gb
Sep 15, 2025Pj045 Decision De La Chambre De Recours De Loeb 1Er April T 140906 Gb
Sep 15, 2025Pj044 Decision De La Chambre De Recours De Loeb DU 28 January T 023715 Gb
Sep 15, 2025Pj043 Basf C25899 Gb
Sep 15, 2025Pj042 Gsk C21013 14 Nov Gb
Sep 15, 2025Pj041 Ca Paris 14 February Rg 1903820 Sandoz C Msd Fr
Sep 15, 2025Pj040 Abraxis C 443 17 21 March Gb
Sep 15, 2025Pj039 Case Law Of The Boards Of Appeal Of The Epo I D74 Try And See Solution Gb
Sep 15, 2025Pj038 Tj Paris 20 January Rg N 1901997 Fr
Sep 15, 2025Pj037 Tj Paris 6 September Rg N2106416 Fr
Sep 15, 2025Pj036 Tj Paris 7 June Rg 2153474 Sanofi C Accord Cabazitaxel Fr
Sep 15, 2025Pj035 Ca Paris 29 October Etypharm C Merck Rg N1803876 Fr
Sep 15, 2025Pj034 Cour Dappel De Paris 18 December Rg N 1710112 Fr
Sep 15, 2025Pj033 Decision De La Chambre De Recours De Loeb 25 July T 025915 Gb
Sep 15, 2025Pj032 Decision De La Chambre De Recours De Loeb 29 May T 009198 Gb
Sep 15, 2025Pj031 Decision De La Chambre De Recours De Loeb 5 October T 33397 Gb
Sep 15, 2025Pj030 Decision De La Chambre De Recours De Loeb 6 October T 91801 Gb
Sep 15, 2025Pj029 Decision De La Chambre De Recours De Loeb 14 February 1989 T 24988 Gb
Sep 15, 2025Pj028 Case Law Of The Boards Of Appeal Of The Epo Id71 Reasonable Expectation Of Success Gb
Sep 15, 2025Pj027 Jurisprudences Francaises Essais De Routine Fr
Sep 15, 2025Pj026 Tgi Paris 7 May Hexal C Boehringer Rg 0812537 Fr
Sep 15, 2025Pj025 Jub Division Centrale De Munich 16 July Sanofi C Amgen Upccfi 12023 Gb
Sep 15, 2025Pj024 Jub Cour Dappel 26 February Nanostring C 10X Genomics Upccoa3352023 Gb
Sep 15, 2025Pj023 Decision De La Chambre De Recours 332 De L Oeb 26 February T 92600 Gb
Sep 15, 2025Pj022 Decision De La Chambre De Recours 332 De Loeb 2 June T 30899 Gb
Sep 15, 2025Pj021 Decision De La Chambre De Recours 352 De Loeb 22 October 1993 T 25392 Gb
Sep 15, 2025Pj020 Decision De La Chambre De Recours 332 De Loeb 13 July T 393 01 Gb
Sep 15, 2025Pj019 Ca Paris 19 January Rg 18 21115 Fr
Sep 15, 2025Pj018 Tj Paris 20 July Rg N 21 10327 Fr
Sep 15, 2025Pj017 Ca Paris 14 November Rg N 1502576 Fr
Sep 15, 2025Pj016 Tj Paris 28 March Rg 2208612 Fr
Sep 15, 2025Pj014 Upc Court Of Appeal 13 August Upccoa4462025 Gb
Sep 15, 2025Pj013 Tj Paris 18 June Rg N 23 02356 Fr
Sep 15, 2025Pj012 Munich Local Division 27 August Upccfi2012024 Gb
Sep 15, 2025Pj011 Tj Paris 27 July Rg N 22 54367 Fr
Sep 15, 2025Pj010 Guidelines For Examination Of The Epo Giv1 Gb
Sep 15, 2025Pj009 Ca Paris 25 May Rg 21 18398 Fr
Sep 15, 2025Pj008 Tj Paris 29 September Rg 21 55930 Fr
Sep 15, 2025Pj007 Tj Paris Ordonnance De Refere 6 October Rg 22 55799 Biogen C Viatris Dmf Fr
Sep 15, 2025Pj006 Cjeu 16 July Genmab V Hungarian Ip Office Spc C 181 24 Gb
Sep 15, 2025Pj005 Accord Cadre Leem Ceps 5 March Fr
Sep 15, 2025Pj004 Regulation No 1768 92 Gb
Sep 15, 2025Pj003 Tj Paris Ordonnance Viatris C Novartis 04 August Fingolimod Rg N 2254655 Fr
Sep 15, 2025Pj002 Ca Paris 14 February Rg 1906114 Fr
Sep 15, 2025Pj001 Decision Du Conseil Constitutionnel N 463 Dc DU 12 December Fr
Sep 15, 2025Pc152 Submissions In High Resolution Gb
Sep 15, 2025Pc151 Declaration Dawid Sierzant DU 15 September Et Annexes Gb
Sep 15, 2025Pc150 4 Aminopyridine C5H6N2 Cid 1727 Pubchem Gb
Sep 15, 2025Pc149 Iqvia Data Unredacted Version Gb
Sep 15, 2025Pc148 The Fixing Of The Price And Reimboursement Rate Sante Gouv Fr
Sep 15, 2025Pc146 Letter From Viatris To Mez DATED 2 July Gb
Sep 15, 2025Pc145 Letter From Viatris To Merz Of 10 July Fr
Sep 15, 2025Pc143 Chapter 33 Pymadin Paskov Et Al 1986 Gb
Sep 15, 2025Pc142 Kostadinova And Danchev Gb
Sep 15, 2025Pc141 Sartori Et Al 1994 Gb
Sep 15, 2025Pc140 Olg Munchen Acorda Therapeutics V Ratiopharm 6 October 6 U 3044 22 De
Sep 15, 2025Pc139 Upsto Trademark Status Document Retrieval Pymadin Sopharma Gb
Sep 15, 2025Pc138 Website Of The Faculty Of Medicine In Sofia Bg
Sep 15, 2025Pc137 They Are Looking For A Superpill For Alzheimers Technologies News Standard Bg
Sep 15, 2025Pc136 Russian State Archive Of Scientific And Technical Documentation Ru
Sep 15, 2025Pc135 Communication Between The Ceps And Viatris Fr
Sep 15, 2025Pc134 Patient Leaflet Pymadin Bg
Sep 15, 2025Pc133 Smpc Pymadin Bg
Sep 15, 2025Pc132 Free State Gazette Edition 33 Of 2Iv Unofficial Section Ru
Sep 15, 2025Pc131 Disaster Protection Plan Burgas Region Republic Of Bulgaria Bg
Sep 15, 2025Pc130 4 Aminopiridin Spinal Cord Injury Forum Ru Compressed
Sep 15, 2025Pc129 Iqvia About Us Gb
Sep 15, 2025Pc128 Adverse Exhibit No 503 Toumi Et Al External Reference Pricing Simulation Gb
Sep 15, 2025Pc122 Application For Provisional Measures Gb
Sep 15, 2025Pc121 Acorda V Alkem Trial Transcript Volume B Gb
Sep 15, 2025Pc120 Acorda V Alkem Trial Transcript Volume A Gb
Sep 15, 2025Pc119 Hamilton Et Al 1998 Olanzapine Versus Placebo And Haloperidol Quality Of Life And Efficacy Results On The North Am
Sep 15, 2025Pc118 Overall 1994 Journal Of Clinical Psychology VOL 50 Pages 95 102 Gb
Sep 15, 2025Pc117 Alhainen Et Al 1991 Discrimination Of Tetrahydroaminoacridine Responders By A Single Dose Pharmaco Eeg In Patients
Sep 15, 2025Pc116 Sas Library 1997 Repeated Measures Anova Using Sas Proc Glm Gb
Sep 15, 2025Pc115 Sheeber Et Al 1996 Data Analytic Techniques For Treatment Outcome Studies With Pretest Posttest Measurements An Ex
Sep 15, 2025Pc114 Cook Et Al 1983 Design And Analysis Methods For Longitudinal Research Ann Rev Public Health Gb
Sep 15, 2025Pc113 Vickers Hor Many Repeated Measures In Repeates Measures Designs Statistical Issues For Comparative Trials Bmc
Sep 15, 2025Pc112 Uryniak Et Al Responder Analyses A Phrma Position Paper Statistics In Biopharmaceutical Research VOL 3 N3 Gb
Sep 15, 2025Pc111 Schulz Et Al The Efficacy Of Quetiapine VS Haloperidol And Placebo A Meta Analytic Study Of Efficacy Schizopp
Sep 15, 2025Pc110 Temple 1994 Commun Stat Theory Meth VOL 23 Pages 449 521 Gb
Sep 15, 2025Pc109 Lewis Statistics In Medicine VOL 21 Pages 2931 2938 Gb
Sep 15, 2025Pc108 Weiner 1998 Can J Neurol Sci VOL 25 Pages 93101 Gb
Sep 15, 2025Pc107 Petkau 1998 Seminars In Neurology VOL 18 3 Gb
Sep 15, 2025Pc106 Leber Et DAVIS 1998 Threats To The Validity Of Clinical Trials Employing Enrichment Strategies For Sample Selectio
Sep 15, 2025Pc105 DTX 584 Gb
Sep 15, 2025Pc104 4 Aminopyridine Induces Functional Improvement In Multiple Sclerosis Patients A Neurophysiological Study Gb
Sep 15, 2025Pc103 Stefoski Et Al 1991 4 Aminopyridine In Multiple Sclerosis Prolonged Administration Neurology 1991 Gb
Sep 15, 2025Pc102 Clinical Studies In 20 Questions Atelier Presse Clinical Trials Leem 19 May Fr
Sep 15, 2025Pc101 Report By Dr Christian Wolf DATED 2 September Gb
Sep 15, 2025Pc100 EP1732548B9 Gb
Sep 15, 2025Pc099 Matusik Therapy Nutrients 14 4249 Gb
Sep 15, 2025Pc098 Le Progres Article Patients Deprived Of A Medication Due To A Change Of Packaging 26 June Fr
Sep 15, 2025Pc097 Screenshots Of Patients Testimonies Online 2 2 Fr
Sep 15, 2025Pc097 Screenshots Of Patients Testimonies Online 1 2 Fr
Sep 15, 2025Pc096 Kehl Responder Identification In Clinical Trials June Gb
Sep 15, 2025Pc095 CPMP Points To Consider Multiplicity Issues Clinical Trials Gb
Sep 15, 2025Pc094 Hayes Et Al Pharmacokinetic Studies Of Single And Multiple Oral Doses Of Fampridine VOL 26 N4 Pp 185 192 Gb
Sep 15, 2025Pc093 Hayes Et Al Pharmacokinetics Of An Immediate Release Oral Formulation Of Fampridine 4 Aminopyridine In Normal
Sep 15, 2025Pc092 July 1986 Comment Determiner La Posologie Optimale D Un Medicament Fr
Sep 15, 2025Pc091 Dose Ranging Study Wikipedia Gb
Sep 15, 2025Pc090 Rnb Ccp 033 Fr
Sep 15, 2025Pc089 Rnb EP536Fr
Sep 15, 2025Pc088 Chmp 1999 Clinical Investigation Of Medicinal Products In The Treatment Of Parkinson S Disease CPMP Note For Guida
Sep 15, 2025Pc087 Ccne Opinion 79 Transposition Into French Law Of The European Directive On Clinical Trials Of Medicinal Products F
Sep 15, 2025Pc086 Declaration Of Helsinki Ethical Principles For Medical Research Involving Human Subjects Gb
Sep 15, 2025Pc085 Nuremberg Code Gb
Sep 15, 2025Pc084 Afsep Press Release Of 28 May Fr
Sep 15, 2025Pc083 Barus Et Al Fr
Sep 15, 2025Pc082 Extrait De La Base De Donnees Publique Des Medicaments Fampridine Viatris 10 Mg Fr
Sep 15, 2025Pc081 Icht Topic 9 Guideline On Statistical Principles For Clinical Trials September 1998 Gb
Sep 15, 2025Pc080 Website Of The Foundation For Research Into Multiple Sclerosis Fr
Sep 15, 2025Pc079 Notice On The Prices Of Fampridine Pharmaceutical Specialities Fr
Sep 15, 2025Pc078 Info Sheet Fampyra 10Mg Sustained Release Tablet Fr
Sep 15, 2025Pc077 Accession Of Bulgaria Gb
Sep 15, 2025Pc076 Kehl Responder Identification In Clinical Trials With Censored Data Gb
Sep 15, 2025Pc075 Federal Court Of Canada 15 May Acorda V Pharmascience And Taro T 1416 18 And T 220 19 Gb
Sep 15, 2025Pc074 Usa Delaware District Court 25 April Acorda V Teva Roxane Mylan 14 882 Gb
Sep 15, 2025Pc073 Usa Delaware District Court 31 March Acorda V Roxane 14 882 Lps Gb
Sep 15, 2025Pc072 Germany Teva Revocation Of Patent EP548De
Sep 15, 2025Pc071 Germany Ratiopharm Revocation Of Patent EP536De
Sep 15, 2025Pc070 Germany Ratiopharm Admissibility Of The EP536Invalidity Claim De
Sep 15, 2025Pc069 Board Of Appeal Of The European Patent Office 4 September T 0799 16 Gb
Sep 15, 2025Pc068 Decision Of The Epo EP536Gb Compressed
Sep 15, 2025Pc067 Emea Points To Consider On The Choice Of Non Interiority Margin Gb
Sep 15, 2025Pc066 Emea 27 July Points To Consider On Switching Betweend Superiority And Non Inferiority Gb
Sep 15, 2025Pc064 Usa Court Of Appeal 10 September Acorda V Roxane Et Al Et 2134 Gb
Sep 15, 2025Pc063 Form 10 K Wikipedia Presentation Gb
Sep 15, 2025Pc062 Cohen Postgraduate Medicine September 1999 Gb
Sep 15, 2025Pc061 L Echelle Edss Expanded Disability Status Scale Fr
Sep 15, 2025Pc060 O Brien Journal Of Hypertension Gb
Sep 15, 2025Pc059 Ellen R Girden Anova Repeated Measures 1992 Gb
Sep 15, 2025Pc058 Federal Court Of Appeal Of Canada 8 August Acorda Therapeutics V Pharmascience Taro Pharmaceuticals A 145 20
Sep 15, 2025Pc057 Fda Chapter I Food And Drug Administration Department Of Health And Human Services Subchapter D Drugs For Human Us
Sep 15, 2025Pc056 Polman Arch Neur VOL 51 November 1994 Gb
Sep 15, 2025Pc055 Sheiner Clin Pharmacol Ther Volume 46 Number 1 July 1989 Gb
Sep 15, 2025Pc054 Norleans Statistical Methods For Clinical Trials Gb Compressed
Sep 15, 2025Pc053 Excerpt From The Fda Website Drug Evaluation Process Gb
Sep 15, 2025Pc052 Schwid Et Al April Gb
Sep 15, 2025Pc051 Kaufman Al The Significant Change For The Timed 25 Foot Walk In The Multiple Sclerosis Functional Composite M
Sep 15, 2025Pc050 Extract From The National Institutes Of Health Website Fda Drug Review And Approval Gb
Sep 15, 2025Pc049 Ca 2 562 277 Gb
Sep 15, 2025Pc048 US8663685Gb
Sep 15, 2025Pc047 US8440703Gb
Sep 15, 2025Pc046 US8354437Gb
Sep 15, 2025Pc045 Declaration Of Dr Ron Cohen Gb
Sep 15, 2025Pc044 US8007826Gb
Sep 15, 2025Pc043 Goodman Diaporama Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb
Sep 15, 2025Pc042 Medical Research Council Mrc Scale For Muscle Strength Gb
Sep 15, 2025Pc041 National Multiple Sclerosis Society Timed 25 Foot Walk T25 Fw Gb
Sep 15, 2025Pc040 Ninds Fatigue Severity Scale Fss Gb
Sep 15, 2025Pc039 Wikipedia Page Edss Gb
Sep 15, 2025Pc038 Goodman Poster Placebo Controlled Double Blinded Dose Ranging Study Of Fampridine Sr In Multiple Sclerosis Gb
Sep 15, 2025Pc037 Supplemental Information Disclosure Statement Gb
Sep 15, 2025Pc036 Actrims Ectrims Final Program Gb Compressed
Sep 15, 2025Pc035 List Of References Ids Gb
Sep 15, 2025Pc034 List Of Documents Requested US11102559Gb
Sep 15, 2025Pc033 Acorda Therapeutics Form S1 Gb
Sep 15, 2025Pc032 Form S 1 Presentation Gb
Sep 15, 2025Pc031 Sec Overview Gb
Sep 15, 2025Pc030 Goodman Abstract Poster Gb
Sep 15, 2025Pc029 Shargel 1999 Applied Biopharmaceutics And Pharmacokinetics Chapter 7 Extraits Pages 169 178 179 Gb Compressed
Sep 15, 2025Pc028 VAN Diemen Et Al 1992 August Gb
Sep 15, 2025Pc027 EP0484186B1 Gb
Sep 15, 2025Pc026 Schwid Et Al 1997 The American Academy Of Neurology Volume 48 Pages 817 821 Gb
Sep 15, 2025Pc025 Bever 1994 The American Neurological Association 1994 Volume 23 Page 118 S121 Gb
Sep 15, 2025Pc024 Bever Et Al 1994 June Neurology 44 1054 1059 Gb
Sep 15, 2025Pc023 Davis Et Al 1990 The American Neurological Association 1990 Pages 186 192 Gb
Sep 15, 2025Pc022 Sherratt Et Al 1980 Nature Volume 283 5745 Pages 570 572 Gb
Sep 15, 2025Pc021 List Of Documents Cited In The Oppositions Gb
Sep 15, 2025Pc020 Merz Acquires Fampyra Gb
Sep 15, 2025Pc019 European Medicines Agency Guidelines Ich Topic E4 November 1994 Gb
Sep 15, 2025Pc018 EP536Oral Proceedings Gb
Sep 15, 2025Pc017 Verhagen Et Al Australian Journal Of Physiotherapy VOL 50 Gb
Sep 15, 2025Pc016 Piece Composite Synthese Wikipiedia Sur L Ecart Type Et La Valeur P Fr
Sep 15, 2025Pc015 Marien Et Beaud Guide Pratique Pour L Utilisation De La Statistique En Recherche Fr
Sep 15, 2025Pc014 Journal De La Societe Statistique De Paris 1956 Fr
Sep 15, 2025Pc013 Ting N Introduction And New Drug Development Process In Ting N Editor Dose Finding In Drug Development Springer Ne
Sep 15, 2025Pc012 Pirmohamed Et Al Bmj Volume 316 25 April 1998 Gb
Sep 15, 2025Pc011 Edwards And Aronson The Lancet VOL 356 October 7 Gb
Sep 15, 2025Pc010 Ich Topic E 8 General Considerations For Clinical Trials 17 July 1997 Gb
Sep 15, 2025Pc009 Griffin Et Al The Textbook Of Pharmaceutical Medicine 1993 Pages 221 222 Gb Compressed
Sep 15, 2025Pc008 Bopi 20 November N 1547 Pp 235 237 Et 258 Fr
Sep 15, 2025Pc007 Decision Et Requete De Delivrance Du Ccp N 13 C0033 Fr
Sep 15, 2025Pc006 Demande De Ccp Sur La Base Du Brevet EP2377536Fr
Sep 15, 2025Pc005 EP2377536B2 Gb
Sep 15, 2025Pc004 Fampyra Smpc Gb
Sep 15, 2025Pc003 Commission Implementing Decision Of 27 September C20246926 Gb
Sep 15, 2025Pc002 Rcp Fampridine Viatris Lp 10Mg Fr
Sep 15, 2025Pc001 Extrait Kbis Viatris Sante Fr
Sep 15, 2025Objection Viatris Sante App 339802025 Compressed Signed
Sep 11, 2025Summon Oral Hearing
Sep 11, 2025Order Summon The Oral Hearing
Aug 18, 2025Procedural Order Timetable And Summon Oh
Aug 18, 2025Hearing Dates
Aug 14, 2025Panel Appointment
Aug 7, 2025Acknowledgement Of Access To Case
Aug 6, 2025Notification Of Service
Aug 6, 2025Digital Tracking La Poste Service Receipt
Aug 5, 2025Panel Appointment
Aug 1, 2025Panel Appointment
Aug 1, 2025Notice To Accompany Service Of Order For Measures
Aug 1, 2025Letter For Service
Aug 1, 2025Formal Checks Notification Of Positive Outcome
Aug 1, 2025Exhibit No. 701 Application French Translation
Aug 1, 2025Exhibit No. 700 Proof Of Payment
Aug 1, 2025Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03
Aug 1, 2025Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02
Aug 1, 2025Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09
Aug 1, 2025Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03
Aug 1, 2025Exhibit No. 604 Coa Biolitec V Light Guide 24.02
Aug 1, 2025Exhibit No. 601 Coa Mammut V Orthovox 25.09
Aug 1, 2025Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10
Aug 1, 2025Exhibit No. 512 Performance Based Remuneration
Aug 1, 2025Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07
Aug 1, 2025Exhibit No. 510 Order Pharmacists Health Insurance 31.03
Aug 1, 2025Exhibit No. 509 Substituting Generic Product On Ameli
Aug 1, 2025Exhibit No. 508 Ceilings For Discounts Decree
Aug 1, 2025Exhibit No. 507 Article L. 138 9
Aug 1, 2025Exhibit No. 506 Cfiec T 201.04 R 22.12
Aug 1, 2025Exhibit No. 505 Cfiec T 114.06 R 20.07
Aug 1, 2025Exhibit No. 504 Leem Economic Extracts
Aug 1, 2025Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation
Aug 1, 2025Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation
Aug 1, 2025Exhibit No. 501 Health Products Agreement
Aug 1, 2025Exhibit No. 500 Notice Amendment Generic Distribution 6.01
Aug 1, 2025Exhibit No. 405 Ema Guideline Mr Dosage Forms
Aug 1, 2025Exhibit No. 404 Acorda Sec S 1 Form
Aug 1, 2025Exhibit No. 403 Goodman Abstract
Aug 1, 2025Exhibit No. 402 Goodman Slideshow
Aug 1, 2025Exhibit No. 401 Goodman Poster
Aug 1, 2025Exhibit No. 400 Who Inn List 35
Aug 1, 2025Exhibit No. 302 Epo T 0421.14 Decision
Aug 1, 2025Exhibit No. 301 Federal Patent Court Decision
Aug 1, 2025Exhibit No. 300 Epo T 0799.16 Decision
Aug 1, 2025Exhibit No. 213 French Patent Annuity Extract
Aug 1, 2025Exhibit No. 212 Acorda And Merz Llc Short Form Assignment
Aug 1, 2025Exhibit No. 211 French Spc Grant Publication
Aug 1, 2025Exhibit No. 210 French Spc Grant Decision
Aug 1, 2025Exhibit No. 209 French Spc Annuity Extract
Aug 1, 2025Exhibit No. 208 French Spc Register
Aug 1, 2025Exhibit No. 207 Upc Opt Out Extract
Aug 1, 2025Exhibit No. 206 French Patent Register
Aug 1, 2025Exhibit No. 205 EP536Patent
Aug 1, 2025Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence
Aug 1, 2025Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence
Aug 1, 2025Exhibit No. 202 Official Intellectual Property Bulletin 25
Aug 1, 2025Exhibit No. 201 French Spc Registration Entries
Aug 1, 2025Exhibit No. 200 French Patent Registration Entries
Aug 1, 2025Exhibit No. 132 Fampyra French Co Payment Notice 04.06
Aug 1, 2025Exhibit No. 131 Fampyra French Price Notice 04.06
Aug 1, 2025Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06
Aug 1, 2025Exhibit No. 129 Fampyra French Reimbursement Order 02.06
Aug 1, 2025Exhibit No. 128 Reply Letter 10.07
Aug 1, 2025Exhibit No. 127 Notice Letter 4.07
Aug 1, 2025Exhibit No. 126 Reply Letter 2.07
Aug 1, 2025Exhibit No. 125 Notice Letter 18.06
Aug 1, 2025Exhibit No. 124 Monthly Gers Fampridine Sales
Aug 1, 2025Exhibit No. 123 Weekly Gers Fampridine Sales
Aug 1, 2025Exhibit No. 122 French Fampridine Ma
Aug 1, 2025Exhibit No. 121 French Co Payment Notice 22.11
Aug 1, 2025Exhibit No. 120 French Price Notice 22.11
Aug 1, 2025Exhibit No. 119 French Public Institution Approval Order 19.11
Aug 1, 2025Exhibit No. 118 French Reimbursement Order 19.11
Aug 1, 2025Exhibit No. 117 French Generics List Decision 19.09
Aug 1, 2025Exhibit No. 116 Fampridine Viatris French Directory
Aug 1, 2025Exhibit No. 115 Fampridine Viatris Pil
Aug 1, 2025Exhibit No. 114 Fampridine Viatris Smpc
Aug 1, 2025Exhibit No. 113 Ema Assessment Report
Aug 1, 2025Exhibit No. 112 Fampyra Eu Definitive Approval
Aug 1, 2025Exhibit No. 111 Eu Marketing Decisions
Aug 1, 2025Exhibit No. 110 Fampyra Eu Conditional Approval
Aug 1, 2025Exhibit No. 109 Fampyra Epar Summary
Aug 1, 2025Exhibit No. 108 Fampyra Smpc
Aug 1, 2025Exhibit No. 107 Fampyra French Directory
Aug 1, 2025Exhibit No. 106 Larocca
Aug 1, 2025Exhibit No. 105 Kasser Et Al.
Aug 1, 2025Exhibit No. 104 Lublin Reingold 1996
Aug 1, 2025Exhibit No. 103 Lucchinetti Et Al.
Aug 1, 2025Exhibit No. 100 Merz Fampyra Launch News
Aug 1, 2025Exhibit No. 013 Acorda Webpage
Aug 1, 2025Exhibit No. 012 Viatris France Webpage
Aug 1, 2025Exhibit No. 011 Viatris Generics Webpage
Aug 1, 2025Exhibit No. 010 Viatris Products Webpage
Aug 1, 2025Exhibit No. 009 Fr Commercial Register Viatris Sante
Aug 1, 2025Exhibit No. 008 Fr Commercial Register Merz Pharma France
Aug 1, 2025Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh
Aug 1, 2025Exhibit No. 006 Merz Acorda Asset News
Aug 1, 2025Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc
Aug 1, 2025Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan
Aug 1, 2025Exhibit No. 003 Merz Therapeutics Website
Aug 1, 2025Exhibit No. 002 Merz Businesses Webpage
Aug 1, 2025Exhibit No. 001 Merz History Webpage
Aug 1, 2025Application For Provisional Measures
Aug 1, 2025Application For Measures Receipt
Aug 1, 2025Application For Measures Acknowledgement
Jul 31, 2025Exhibit No. 700 Proof Of Payment
Jul 31, 2025Exhibit No. 608 Coa 10X Genomics V Nanostring 11.03
Jul 31, 2025Exhibit No. 607 Coa 10X Genomics V Nanostring 26.02
Jul 31, 2025Exhibit No. 606 Ld Munich 10X Genomics V Nanostring 19.09
Jul 31, 2025Exhibit No. 605 Coa Sumi Agro V Syngenta 3.03
Jul 31, 2025Exhibit No. 604 Coa Biolitec V Light Guide 24.02
Jul 31, 2025Exhibit No. 601 Coa Mammut V Orthovox 25.09
Jul 31, 2025Exhibit No. 600 Ld Dusseldorf VALEO V Magna 31.10
Jul 31, 2025Exhibit No. 512 Performance Based Remuneration
Jul 31, 2025Exhibit No. 511 Amendment Order Pharmacists Health Insurance 5.07
Jul 31, 2025Exhibit No. 510 Order Pharmacists Health Insurance 31.03
Jul 31, 2025Exhibit No. 509 Substituting Generic Product On Ameli
Jul 31, 2025Exhibit No. 508 Ceilings For Discounts Decree
Jul 31, 2025Exhibit No. 507 Article L. 138 9
Jul 31, 2025Exhibit No. 506 Cfiec T 201.04 R 22.12
Jul 31, 2025Exhibit No. 505 Cfiec T 114.06 R 20.07
Jul 31, 2025Exhibit No. 504 Leem Economic Extracts
Jul 31, 2025Exhibit No. 503 Toumi Et Al. External Reference Pricing Simulation
Jul 31, 2025Exhibit No. 502 Kanavos Et Al. External Reference Pricing Implementation
Jul 31, 2025Exhibit No. 501 Health Products Agreement
Jul 31, 2025Exhibit No. 500 Notice Amendment Generic Distribution 6.01
Jul 31, 2025Exhibit No. 405 Ema Guideline Mr Dosage Forms
Jul 31, 2025Exhibit No. 404 Acorda Sec S 1 Form
Jul 31, 2025Exhibit No. 403 Goodman Abstract
Jul 31, 2025Exhibit No. 402 Goodman Slideshow
Jul 31, 2025Exhibit No. 401 Goodman Poster
Jul 31, 2025Exhibit No. 400 Who Inn List 35
Jul 31, 2025Exhibit No. 302 Epo T 0421.14 Decision
Jul 31, 2025Exhibit No. 301 Federal Patent Court Decision
Jul 31, 2025Exhibit No. 300 Epo T 0799.16 Decision
Jul 31, 2025Exhibit No. 213 French Patent Annuity Extract
Jul 31, 2025Exhibit No. 212 Acorda And Merz Llc Short Form Assignment
Jul 31, 2025Exhibit No. 211 French Spc Grant Publication
Jul 31, 2025Exhibit No. 210 French Spc Grant Decision
Jul 31, 2025Exhibit No. 209 French Spc Annuity Extract
Jul 31, 2025Exhibit No. 208 French Spc Register
Jul 31, 2025Exhibit No. 207 Upc Opt Out Extract
Jul 31, 2025Exhibit No. 206 French Patent Register
Jul 31, 2025Exhibit No. 205 EP536Patent
Jul 31, 2025Exhibit No. 204 Merz Gmbh And Merz France Short Form Sub Licence
Jul 31, 2025Exhibit No. 203 Merz Llc And Merz Gmbh Short Form Licence
Jul 31, 2025Exhibit No. 202 Official Intellectual Property Bulletin 25
Jul 31, 2025Exhibit No. 201 French Spc Registration Entries
Jul 31, 2025Exhibit No. 200 French Patent Registration Entries
Jul 31, 2025Exhibit No. 132 Fampyra French Co Payment Notice 04.06
Jul 31, 2025Exhibit No. 131 Fampyra French Price Notice 04.06
Jul 31, 2025Exhibit No. 130 Fampyra French Public Institution Approval Order 02.06
Jul 31, 2025Exhibit No. 129 Fampyra French Reimbursement Order 02.06
Jul 31, 2025Exhibit No. 128 Reply Letter 10.07
Jul 31, 2025Exhibit No. 127 Notice Letter 4.07
Jul 31, 2025Exhibit No. 126 Reply Letter 2.07
Jul 31, 2025Exhibit No. 125 Notice Letter 18.06
Jul 31, 2025Exhibit No. 124 Monthly Gers Fampridine Sales
Jul 31, 2025Exhibit No. 123 Weekly Gers Fampridine Sales
Jul 31, 2025Exhibit No. 122 French Fampridine Ma
Jul 31, 2025Exhibit No. 121 French Co Payment Notice 22.11
Jul 31, 2025Exhibit No. 120 French Price Notice 22.11
Jul 31, 2025Exhibit No. 119 French Public Institution Approval Order 19.11
Jul 31, 2025Exhibit No. 118 French Reimbursement Order 19.11
Jul 31, 2025Exhibit No. 117 French Generics List Decision 19.09
Jul 31, 2025Exhibit No. 116 Fampridine Viatris French Directory
Jul 31, 2025Exhibit No. 115 Fampridine Viatris Pil
Jul 31, 2025Exhibit No. 114 Fampridine Viatris Smpc
Jul 31, 2025Exhibit No. 113 Ema Assessment Report
Jul 31, 2025Exhibit No. 112 Fampyra Eu Definitive Approval
Jul 31, 2025Exhibit No. 111 Eu Marketing Decisions
Jul 31, 2025Exhibit No. 110 Fampyra Eu Conditional Approval
Jul 31, 2025Exhibit No. 109 Fampyra Epar Summary
Jul 31, 2025Exhibit No. 108 Fampyra Smpc
Jul 31, 2025Exhibit No. 107 Fampyra French Directory
Jul 31, 2025Exhibit No. 106 Larocca
Jul 31, 2025Exhibit No. 105 Kasser Et Al.
Jul 31, 2025Exhibit No. 104 Lublin Reingold 1996
Jul 31, 2025Exhibit No. 103 Lucchinetti Et Al.
Jul 31, 2025Exhibit No. 100 Merz Fampyra Launch News
Jul 31, 2025Exhibit No. 013 Acorda Webpage
Jul 31, 2025Exhibit No. 012 Viatris France Webpage
Jul 31, 2025Exhibit No. 011 Viatris Generics Webpage
Jul 31, 2025Exhibit No. 010 Viatris Products Webpage
Jul 31, 2025Exhibit No. 009 Fr Commercial Register Viatris Sante
Jul 31, 2025Exhibit No. 008 Fr Commercial Register Merz Pharma France
Jul 31, 2025Exhibit No. 007 De Commercial Register Merz Therapeutics Gmbh
Jul 31, 2025Exhibit No. 006 Merz Acorda Asset News
Jul 31, 2025Exhibit No. 005 Us Commercial Register Merz Pharmaceuticals Llc
Jul 31, 2025Exhibit No. 004 Acorda Bankruptcy Proceedings And Liquidation Plan
Jul 31, 2025Exhibit No. 003 Merz Therapeutics Website
Jul 31, 2025Exhibit No. 002 Merz Businesses Webpage
Jul 31, 2025Exhibit No. 001 Merz History Webpage
Jul 31, 2025Application For Provisional Measures

More cases involving EP2377536B2

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ACT_33980/2025Jul 31, 2025Merz Pharmaceuticals, Merz Pharma France, Merz TherapeuticsViatris Sante

More cases involving Merz Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ACT_33980/2025Jul 31, 2025Merz PharmaceuticalsViatris Sante

More cases involving Viatris Sante

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
ACT_33980/2025Jul 31, 2025Merz Pharmaceuticals, Merz Pharma France, Merz TherapeuticsViatris Sante